Beranda › Diabetes Tipe 2 › Alabama › Birmingham
Uji klinis Diabetes Tipe 2 di Birmingham, AL
16 studi untuk Diabetes Tipe 2 mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Menerima peserta
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Menerima peserta
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Menerima pesertaFase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Menerima pesertaFase 3
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Menerima pesertaFase 2
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Menerima pesertaFase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Menerima peserta
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Menerima pesertaFase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Menerima peserta
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Menerima pesertaFase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Menerima pesertaStudi observasional
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Menerima peserta
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Menerima peserta
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Uji klinis Diabetes Tipe 2 di kota lain
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- PPOK17 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Fibrosis Kistik16 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.